A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight but Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Trial Identifier: D7830C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04142424
Start Date: October 2019
Primary Completion Date: November 2021
Study Completion Date: November 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation
Simplified Chinese Translation
Traditional Chinese Translation

Trial Locations

Country Location
United States of America, CA Glendale, CA, United States of America, 91206